The Biden administration announces the largest permanent increase in SNAP benefits history; a potential decision timeline on whether to offer COVID-19 booster shots to Americans may be on the horizon; children hospitalized with COVID-19 reaches a new record high.
The Biden administration is set to announce today revisions to the nutrition standards of the Supplemental Nutrition Assistance Program (SNAP) benefits program, formerly known as the Food Stamp Program, that will increase average benefits by more than 25% from prepandemic levels. Reported by The New York Times, all 42 million people enrolled in the program, or every 1 in 8 Americans, will receive additional aid, with average monthly benefits rising by $36 from $121 per person before the pandemic. This move marks the largest permanent increase in the program’s history
As reported by The Associated Press, the director of the National Institutes of Health, Francis Collins, MD, PhD, said yesterday that the decision on whether to offer COVID-19 booster shots to Americans could come this fall. Following the FDA’s decision to authorize an extra Pfizer or Moderna vaccine dose for immunocompromised individuals, data from preliminary studies in Israel on the Pfizer/BioNTech vaccine indicate that the vaccine’s protection against severe illness has diminished among those vaccinated in January. If expanded, the booster dose could go first to health care workers, nursing home residents, and other elderly people.
The amount of US children hospitalized with COVID-19 reached a record high of 1902 this past Saturday, with children currently accounting for 2.4% of the nation’s COVID-19 hospitalizations. Reported by Reuters, record highs in the number of patients newly hospitalized witg COVID-19 were also observed last week in individuals aged 18 to 29, 30 to 39, and 40 to 49 years. Notably, one-fifth of COVID-19 hospitalizations are in Florida, whose governor, Ron DeSantis, issued a ban on mask mandates in schools and across the state.
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More